Cerity Partners’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,965
| Closed | -$554K | – | 2410 |
|
|
2024
Q1 | $554K | Sell |
36,965
-88,261
| -70% | -$1.32M | ﹤0.01% | 1551 |
|
|
2023
Q4 | $1.88M | Buy |
+125,226
| New | +$1.88M | 0.01% | 781 |
|
|
2023
Q3 | – | Sell |
-125,226
| Closed | -$1.3M | – | 1704 |
|
|
2023
Q2 | $1.3M | Hold |
125,226
| – | – | 0.01% | 841 |
|
|
2023
Q1 | $1.16M | Hold |
125,226
| – | – | ﹤0.01% | 911 |
|
|
2022
Q4 | $1.11M | Hold |
125,226
| – | – | 0.01% | 669 |
|
|
2022
Q3 | $1.04M | Hold |
125,226
| – | – | 0.01% | 510 |
|
|
2022
Q2 | $1.03M | Sell |
125,226
-3,029
| -2% | -$24.8K | 0.01% | 545 |
|
|
2022
Q1 | $1.12M | Hold |
128,255
| – | – | 0.02% | 426 |
|
|
2021
Q4 | $1.22M | Buy |
128,255
+118,214
| +1,177% | +$1.12M | 0.02% | 404 |
|
|
2021
Q3 | $169K | Hold |
10,041
| – | – | ﹤0.01% | 658 |
|
|
2021
Q2 | $153K | Hold |
10,041
| – | – | ﹤0.01% | 686 |
|
|
2021
Q1 | $196K | Buy |
+10,041
| New | +$196K | ﹤0.01% | 667 |
|